Molecular and microenvironmental drivers of malignant transformation from oral potentially malignant disorders to oral squamous cell carcinoma - Report - MDSpire

Molecular and microenvironmental drivers of malignant transformation from oral potentially malignant disorders to oral squamous cell carcinoma

  • By

  • Vasundra V.

  • Shajitha R.

  • Sundaresan S.

  • Magesh R.

  • June 3, 2026

  • 0 min

Share

Factors Influencing the Malignant Progression from Oral Potentially Malignant Disorders to Oral Squamous Cell Carcinoma

Overview

This review discusses the complex mechanisms driving the progression of oral potentially malignant disorders (OPMDs) to oral squamous cell carcinoma (OSCC). It emphasizes the role of molecular alterations, microenvironmental changes, and the need for improved risk assessment strategies.

Background

Oral squamous cell carcinoma (OSCC) is a prevalent and aggressive form of oral cancer, particularly in regions with high tobacco and alcohol use. The transition from OPMDs to OSCC poses significant clinical challenges due to the limitations of current diagnostic methods. Understanding the biological processes involved in this progression is crucial for early detection and effective intervention.

Data Highlights

No numerical data available in the source material.

Key Findings

  • OPMDs exhibit heterogeneous clinical behavior and varying malignant transformation rates.
  • Molecular alterations, including dysregulation of key signaling pathways, are critical in the progression to OSCC.
  • Chronic inflammation and microenvironmental changes contribute to a pro-tumorigenic niche.
  • Emerging biomarkers and multi-omics approaches may enhance early detection and risk stratification.
  • Current morphology-based diagnostics are inadequate for predicting malignant transformation.

Clinical Implications

Healthcare professionals should consider integrating molecular and genomic assessments into routine evaluations of OPMDs to improve risk prediction. Understanding the dynamic nature of these lesions can guide more effective surveillance and treatment strategies.

Conclusion

The review highlights the need for a paradigm shift in the understanding of OPMDs as dynamic systems, emphasizing the importance of molecular insights for improving patient outcomes in oral cancer.

Related Resources & Content

  1. npj Digital Medicine, 2025 -- AI-driven prediction of progression to oral squamous cell carcinoma using a multiresolution pathology model
  2. Frontiers in Immunology, 2026 -- The microbiome-inflammation-immune axis in oral squamous cell carcinoma: from mechanistic insights to therapeutic perspectives
  3. conexiant, 2026 -- Mutational Signatures May Define Oral Cancers
  4. Frontiers in Oncology, 2026 -- Predicting survival in oral squamous cell carcinoma via integrated analysis of tumor budding and tertiary lymphoid structures
  5. Oral Cancer Guideline | American Dental Association, 2026 -- Oral Cancer Guideline
  6. Frontiers, 2025 -- Malignant transformation rate of oral precancerous disorders to oral cancer: systematic review and meta-analysis of the current evidence
  7. Clinical efficacy of chemopreventive agents in oral cancer and oral potentially malignant disorders: A systematic review - ScienceDirect, 2026
  8. Oral Cancer Guideline | American Dental Association
  9. Frontiers | Malignant transformation rate of oral precancerous disorders to oral cancer: systematic review and meta-analysis of the current evidence
  10. Clinical efficacy of chemopreventive agents in oral cancer and oral potentially malignant disorders: A systematic review - ScienceDirect

Original Source(s)

Related Content